Answers are grounded in this paper and cite their sources.
Objectives This study involves a postal survey of bereaved informal carers of patients that participated in a cluster randomised controlled trial of clinically assisted hydration in the last days of life (‘CHELsea II trial’). Methods The survey was sent out 8 weeks after the patient’s death and asked about whether the informal carer felt the clinical trial had interfered with the end-of-life care the patient had received, whether it had interfered with interactions between the patient and themselves/other persons, whether it had been a negative experience for the patient and whether it had been a negative experience for themselves. Results 950 informal carers were sent the survey, and 477 (50%) returned a completed questionnaire. Only 2% thought that the clinical trial had interfered with the care the patient received, and only 3.5% thought that it had been a negative experience for the patient (and for themselves). Expressions of negativity were associated with dissatisfaction with control of symptoms, and specifically control of distress/agitation. The majority would feel comfortable for another relative (86.5%), and for themselves (88%), to take part in a similar clinical trial. Discussion This survey confirms that research (including interventional clinical trials) can be undertaken in the last days of life without impacting on clinical care, or the interaction between patients and their informal carers. Moreover, it confirms that research participation was generally a positive experience for the patients, and also for the carers.
No takes yet. Share an insight, caveat, or question.
White et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: